Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Medicinas Complementárias
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Bone Miner Metab ; 37(2): 243-255, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29785666

RESUMEN

Selective androgen receptor modulators (SARMs) have shown beneficial effects on muscle wasting, general physical function and bone properties in male mammals. However, data on the effects of SARMs in postmenopausal osteoporotic bone are scarce. We evaluated the effects of the SARM drug ostarine on postmenopausal osteoporotic bone in a rat osteoporosis model. Ovariectomy was performed on 46 of 56 3-month-old female Sprague-Dawley rats. Eight weeks after ovariectomy, ostarine was orally administered daily for 5 weeks in dosages of 0.04 (low, OVX + Ost. 0.04), 0.4 (intermediate, OVX + Ost. 0.4), and 4 mg/kg (high, OVX + Ost. 4) body weight. Another ovariectomized group received no ostarine. Lumbar vertebrae and femora were removed for biomechanical, gene expression, ashing, and computer tomography analyses. Low dose showed no effects. The effects of intermediate and high doses were comparable overall. Improvements were mainly seen in structural properties such as bone mineral density and bone volume density. However, the effects in femora were superior to effects in vertebrae. Ostarine treatment for 5 weeks did not improve significantly biomechanical properties. mRNA expression of the receptor activator of NF-κB ligand decreased after treatment, and uterine weight increased. Serum levels of phosphorus increased following ostarine treatment in intermediate and high-dose groups. Short-term treatment of osteoporotic bone with ostarine leads to improvement of several microstructural bone indices. While we did not observe changes in biomechanics, it is conceivable that longer treatment may also improve biomechanical properties. Further studies are needed to characterize longer time effects and side effects of ostarine in osteoporosis.


Asunto(s)
Anilidas/uso terapéutico , Osteoporosis Posmenopáusica/tratamiento farmacológico , Receptores Androgénicos/metabolismo , Fosfatasa Alcalina/sangre , Anilidas/farmacología , Animales , Fenómenos Biomecánicos , Peso Corporal/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Femenino , Fémur/diagnóstico por imagen , Fémur/efectos de los fármacos , Humanos , Minerales/metabolismo , Músculos/efectos de los fármacos , Músculos/patología , Tamaño de los Órganos/efectos de los fármacos , Osteoporosis Posmenopáusica/sangre , Osteoporosis Posmenopáusica/fisiopatología , Ovariectomía , Fósforo/sangre , Ligando RANK/genética , Ligando RANK/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Sprague-Dawley , Columna Vertebral/diagnóstico por imagen , Columna Vertebral/efectos de los fármacos , Microtomografía por Rayos X
2.
Bone ; 101: 134-144, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28455215

RESUMEN

Osteoporosis is one of the most common diseases worldwide. In osteoporosis, vertebral fractures represent a major burden. Lipoxygenase (LOX) inhibitors such as baicalein and zileuton may represent a promising therapeutic option owing to their antioxidative effects and suppression of various inflammatory processes in muscle and bone. The effect of these LOX inhibitors on the spine was studied in osteopenic rats. Female Sprague-Dawley rats were divided two times into five groups: four groups each were ovariectomized (OVX) and one control group was non-ovariectomized (NON-OVX). Eight weeks after ovariectomy, three concentrations of baicalein (1mg/kg body weight [BW], 10mg/kgBW, and 100mg/kgBW) were administered subcutaneously daily in three OVX groups for 4weeks. Similarly, zileuton was administered in three concentrations via food for 5weeks. In vivo computed tomography (pQCT) of the spine was performed before the treatments and at the end of the experiment. Lumbar vertebrae were subjected to a compression test, micro-CT, and ashing analyses. After baicalein treatment, cortical bone mineral density (BMD) was improved; trabecular connectivity and trabecular BMD were diminished at high dose. After zileuton treatment, the total BMD, anorganic weight, trabecular nodes, and trabecular area were improved. The in vivo stress-strain index was increased and alkaline phosphatase activity in serum was enhanced after both treatments. A dose-dependent effect was not clearly observed after both treatments. The treatments using baicalein for 4 and zileuton for 5weeks were not sufficient to change the biomechanical properties and bone volume fraction (BV/TV). Overall, baicalein improved the cortical bone parameters whereas zileuton had a favorable effect on the trabecular structure. Moreover, both treatments increased the bone formation rate. Longer trials, a combination of both LOX inhibitors, and their effect at the cellular and molecular levels should be investigated in further studies.


Asunto(s)
Flavanonas/farmacología , Hidroxiurea/análogos & derivados , Inhibidores de la Lipooxigenasa/farmacología , Animales , Densidad Ósea/efectos de los fármacos , Enfermedades Óseas Metabólicas/tratamiento farmacológico , Hueso Esponjoso/efectos de los fármacos , Femenino , Flavanonas/uso terapéutico , Hidroxiurea/farmacología , Hidroxiurea/uso terapéutico , Inhibidores de la Lipooxigenasa/uso terapéutico , Vértebras Lumbares/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Ovariectomía , Ratas , Ratas Sprague-Dawley
3.
J Bone Miner Metab ; 35(1): 31-39, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26825660

RESUMEN

We investigated the combinatorial effects of whole-body vertical vibration (WBVV) with the primarily osteoanabolic parathyroid hormone (PTH) and the mainly antiresorptive strontium ranelate (SR) in a rat model of osteoporosis. Ovariectomies were performed on 76 three-month-old Sprague-Dawley rats (OVX, n = 76; NON-OVX, n = 12). After 8 weeks, the ovariectomized rats were divided into 6 groups. One group (OVX + PTH) received daily injections of PTH (40 µg/kg body weight/day) for 6 weeks. Another group (OVX + SR) was fed SR-supplemented chow (600 mg/kg body weight/day). Three groups (OVX + VIB, OVX + PTH + VIB, and OVX + SR + VIB) were treated with WBVV twice a day at 70 Hz for 15 min. Two groups (OVX + PTH + VIB, OVX + SR + VIB) were treated additionally with PTH and SR, respectively. The rats were killed at 14 weeks post-ovariectomy. The lumbar vertebrae and femora were removed for biomechanical and morphological assessment. PTH produced statistically significant improvements in biomechanical and structural properties, including bone mineral density (BMD) and trabecular bone quality. In contrast, SR treatment exerted mild effects, with significant effects in cortical thickness only. SR produced no significant improvement in biomechanical properties. WBVV as a single or an adjunctive therapy produced no significant improvements. In conclusion, vibration therapy administered as a single or dual treatment had no significant impact on bones affected by osteoporosis. PTH considerably improved bone quality in osteoporosis cases and is superior to treatment with SR.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Osteoporosis/tratamiento farmacológico , Osteoporosis/metabolismo , Hormona Paratiroidea/farmacología , Tiofenos/farmacología , Vibración/efectos adversos , Animales , Modelos Animales de Enfermedad , Femenino , Fémur/metabolismo , Vértebras Lumbares/metabolismo , Ratas , Ratas Sprague-Dawley
4.
J Appl Microbiol ; 110(6): 1485-94, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21410852

RESUMEN

AIMS: To determine the effects of cysteine, cystine, proline and thioproline as sporulation medium supplements on Bacillus subtilis spore resistance to hydrogen peroxide (H(2)O(2)), wet heat, and germicidal 254 nm and simulated environmental UV radiation. METHODS AND RESULTS: Bacillus subtilis spores were prepared in a chemically defined liquid medium, with and without supplementation of cysteine, cystine, proline or thioproline. Spores produced with thioproline, cysteine or cystine were more resistant to environmentally relevant UV radiation at 280-400 and 320-400 nm, while proline supplementation had no effect. Spores prepared with cysteine, cystine or thioproline were also more resistant to H(2)O(2) but not to wet heat or 254-nm UV radiation. The increases in spore resistance attributed to the sporulation supplements were eliminated if spores were chemically decoated. CONCLUSIONS: Supplementation of sporulation medium with cysteine, cystine or thioproline increases spore resistance to solar UV radiation reaching the Earth's surface and to H(2)O(2). These effects were eliminated if the spores were decoated, indicating that alterations in coat proteins by different sporulation conditions can affect spore resistance to some agents. SIGNIFICANCE AND IMPACT OF THE STUDY: This study provides further evidence that the composition of the sporulation medium can have significant effects on B. subtilis spore resistance to UV radiation and H(2)O(2). This knowledge provides further insight into factors influencing spore resistance and inactivation.


Asunto(s)
Bacillus subtilis/efectos de la radiación , Medios de Cultivo/química , Calor , Peróxido de Hidrógeno/farmacología , Protectores contra Radiación/farmacología , Rayos Ultravioleta , Bacillus subtilis/efectos de los fármacos , Cisteína/química , Cistina/química , Prolina/química , Esporas Bacterianas/efectos de los fármacos , Esporas Bacterianas/efectos de la radiación , Tiazolidinas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA